Videos

Some 300,000 people overcame cancer in Belgium in the past decade. Great news, but there is a downside: chemotherapy can cause permanent damage to the sense of hearing and balance, leading to hearing loss, tinnitus, or balance problems. To better identify the problem, Heleen Vander Biest (UGent) will test patients' ears just before starting, during, and after chemotherapy.

If you get a glioblastoma, you usually only have about 15 months to live.This malignant tumour spreads rapidly through the brain and unfortunately cannot be cured. Yanti De Visser is working on a personalised treatment to already slow down the brain tumour - with success. "The first results show that our approach has the potential to extend patients' lives by years, rather than months," she says.

Why do people get cancer, arthritis, or Alzheimer's? Essentially because a protein key in our body does not fit in its respective lock. This is why Alvaro Martin is looking at removing defective keys and designing new protein keys. Keys that fit and can open the necessary locks, so that for example, our immune cells target and kill cancerous cells. "Protein design can be the key to unlocking a future without diseases."

Up to 25% of the cells present in lung cancer tumours are currently ignored. As such, we don't know what the role of these so-called B cells is. "It is crucial to figure that out because we cannot efficiently fight something we do not fully understand," says Pauline Bardet (VUB - VIB - FWO).

In her PhD, she wants to get to the bottom of those B cells and thus find out whether those cells are "good guys" or "bad guys".

When removing a kidney tumor, a surgeon has just 20 minutes to do the job. During the operation, the surgeon has to cut off the blood supply to the kidney to avoid a true blood bath. But if the kidney is without blood for too long, too much of it will die off, causing the kidney to malfunction. Using mathematical models, Saar Vermijs aims to help surgeons in their race against the clock...

Today, we can treat cancer better than ever. Yet some cancer types remain very difficult to fight. Such is the case of glioblastoma, a highly aggressive brain cancer in which only 7 in 100 patients are still alive five years after diagnosis. Hoping to help glioblastoma get small, Joke Deschildre doctored a sophisticated strategy to attack cancer cells.

As if developing a cancer drug is not difficult enough, you still have to successfully get that medicine to the tumor. Tim Bomberna (Ghent University) explains how computer simulations show us the way.

Melanoma is a very common and lethal type of skin cancer. Melanoma cells have a strange, yet effective defence mechanism called autophagy: they can manage to survive by eating parts of themselves. Monica Vara Perez tries to figure out this self-cannibalism mechanism in order to help defeat melanoma.

Immunotherapy is increasingly being used in the fight against cancer. But this therapy does not work for all patients. You would think that if it doesn't work, it doesn't it hurt. Unfortunately, it does! Marlies Vanden Bempt (VIB - KU Leuven) explains why.

Despite recent advances in breast cancer treatment, too many women still die once this cancer has spread throughout their body. That's why Matteo Rossi is looking to find weaknesses of breast cancer cells, in order to defeat them.

Waiting for results after a medical examination often causes stress and uncertainty, especially in cancer patients. That is why Elien De Thaye is working on a method to determine the effect of a chemo treatment on people with peritoneal cancer more quickly on the basis of a so-called marker in the blood.

Up to 91 pills a week. That's how many medicines people take at the end of their lives. Kristel Paque is investigating whether all these pills are really necessary.